APA (7th ed.) Citation

AJ, M., M, V., Y, G., A, N., L, G., AA, D., . . . A, B. (2025). Genomic and proteomic profiling of GATA3 mutant metastatic hormone receptor-positive breast cancer and impact on clinical outcomes. Breast cancer research and treatment, 212(3), 437. https://doi.org/10.1007/s10549-025-07710-w

Chicago Style (17th ed.) Citation

AJ, Medford, et al. "Genomic and Proteomic Profiling of GATA3 Mutant Metastatic Hormone Receptor-positive Breast Cancer and Impact on Clinical Outcomes." Breast Cancer Research and Treatment 212, no. 3 (2025): 437. https://doi.org/10.1007/s10549-025-07710-w.

MLA (9th ed.) Citation

AJ, Medford, et al. "Genomic and Proteomic Profiling of GATA3 Mutant Metastatic Hormone Receptor-positive Breast Cancer and Impact on Clinical Outcomes." Breast Cancer Research and Treatment, vol. 212, no. 3, 2025, p. 437, https://doi.org/10.1007/s10549-025-07710-w.